CYTOVIA Inc. IMMUNE Pharmas Oncology Subsidiary Announces the Publication of New Results in the British Journal of Haematology and Filing of a Worldwide Patent Protecting the Use of Ceplene in Chronic Myeloid Leukemia CML

Strengthens Intellectual property portfolio and expands potential clinical use and market opportunity Cytovia the oncology subsidiary of Immune Pharmaceuticals NASDAQIMNP "Immune" or the Company a clinical stage biophar...